Lyell Immunopharma (LYEL) Short Interest Ratio & Short Volume → RE: Your account status (From MarketBeat) (Ad) Free LYEL Stock Alerts $2.75 -0.02 (-0.72%) (As of 05/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Lyell Immunopharma Short Interest DataCurrent Short Interest20,100,000 sharesPrevious Short Interest19,970,000 sharesChange Vs. Previous Month+0.65%Dollar Volume Sold Short$52.46 millionShort Interest Ratio23.3 Days to CoverLast Record DateMay 15, 2024Outstanding Shares254,940,000 sharesFloat Size118,440,000 sharesShort Percent of Float16.97%Today's Trading Volume295,941 sharesAverage Trading Volume933,692 sharesToday's Volume Vs. Average32% Short Selling Lyell Immunopharma ? Sign up to receive the latest short interest report for Lyell Immunopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLYEL Short Interest Over TimeLYEL Days to Cover Over TimeLYEL Percentage of Float Shorted Over Time Ad Resource Stock DigestDigitizing the $11T commodities sector with one tiny stockOne tiny company — trading completely undiscovered around 15-cents per share — has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. It’s an opportunity that likely won’t stay at these levels for long Lyell Immunopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202420,100,000 shares $52.46 million +0.7%17.0%23.3 $2.61 4/30/202419,970,000 shares $43.33 million +9.5%16.9%22.3 $2.17 4/15/202418,230,000 shares $43.75 million +0.7%15.5%19.8 $2.40 3/31/202418,100,000 shares $40.36 million +74.4%15.5%18.8 $2.23 3/15/202410,380,000 shares $22.42 million -5.2%8.9%10.3 $2.16 2/29/202410,950,000 shares $31.97 million -39.6%9.4%8.9 $2.92 Get the Latest News and Ratings for LYEL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lyell Immunopharma and its competitors with MarketBeat's FREE daily newsletter. 2/15/202418,130,000 shares $34.45 million +67.3%15.7%14.5 $1.90 1/31/202410,840,000 shares $19.84 million -30.6%9.4%8.2 $1.83 1/15/202415,620,000 shares $34.68 million +4.4%12.7%11.8 $2.22 12/31/202314,960,000 shares $29.02 million -13.2%12.1%12.2 $1.94 12/15/202317,240,000 shares $33.10 million -0.6%14.0%15.3 $1.92 11/30/202317,340,000 shares $30.00 million -2.3%14.1%18.8 $1.73 11/15/202317,740,000 shares $36.37 million -7.6%14.4%20.3 $2.05 10/31/202319,200,000 shares $31.78 million -7.3%15.8%25.1 $1.66 10/15/202320,720,000 shares $33.98 million -2.3%17.1%29.2 $1.64 9/30/202321,210,000 shares $31.18 million +1.3%17.5%30 $1.47 9/15/202320,930,000 shares $35.37 million -5.2%17.2%28.3 $1.69 8/31/202322,070,000 shares $52.75 million -3.7%18.3%24.3 $2.39 8/15/202322,910,000 shares $52.46 million -2.5%19.0%23 $2.29 7/31/202323,500,000 shares $67.92 million +1.5%19.6%22 $2.89 7/15/202323,160,000 shares $67.86 million -1.2%19.3%20.9 $2.93 6/30/202323,450,000 shares $74.57 million +3.9%19.6%20.8 $3.18 6/15/202322,580,000 shares $87.16 million +4.9%18.9%18.7 $3.86 5/31/202321,530,000 shares $68.68 million +2.8%18.0%20.1 $3.19 5/15/202320,950,000 shares $63.06 million +3.2%17.5%19.8 $3.01 4/30/202320,300,000 shares $41.21 million -0.7%17.0%20.1 $2.03 4/15/202320,450,000 shares $48.26 million -1.8%17.1%20.9 $2.36 3/31/202320,830,000 shares $49.16 million +1.3%17.4%20.2 $2.36 3/15/202320,560,000 shares $45.03 million +14.2%17.2%19.6 $2.19 2/28/202318,010,000 shares $38.72 million +5.4%15.1%16.2 $2.15 2/15/202317,080,000 shares $42.70 million -2.1%14.3%15.7 $2.50 1/31/202317,440,000 shares $57.03 million -2.9%14.6%15.2 $3.27 1/15/202317,960,000 shares $58.01 million -9.4%15.0%15.5 $3.23 12/30/202219,820,000 shares $68.78 million +15.8%20.3%18 $3.47 12/15/202217,110,000 shares $56.12 million -2.0%17.5%16.1 $3.28 11/30/202217,450,000 shares $73.46 million -5.7%22.0%15.3 $4.21 11/15/202218,510,000 shares $85.15 million -2.5%23.4%16.5 $4.60 10/31/202218,990,000 shares $111.66 million -1.1%23.4%18.6 $5.88 10/15/202219,200,000 shares $125.57 million +5.1%23.6%18.6 $6.54 9/30/202218,270,000 shares $133.92 million +19.3%22.5%18.6 $7.33🚀 Tap into this explosive trade opportunity asap (Ad)I learned about these explosive stocks during my two decades on Wall Street… And used them to help grow my old hedge fund from just a few million to over $700 million dollars*. So it’s safe to say… these bad boys work. What’s the secret behind these special trades? Well, right now, I’m going public with the unique strategy behind these “Calendar Stocks”…Go here to see how you can exploit my next “Calendar Stock”. 9/15/202215,320,000 shares $121.95 million +7.0%19.1%14.7 $7.96 8/31/202214,320,000 shares $95.94 million -7.2%18.1%15.6 $6.70 8/15/202215,430,000 shares $116.03 million -4.6%19.5%17.1 $7.52 7/31/202216,180,000 shares $90.12 million -4.9%25.4%17.1 $5.57 7/15/202217,010,000 shares $100.36 million -2.4%26.7%19.1 $5.90 6/30/202217,430,000 shares $113.64 million +6.9%27.4%19.3 $6.52 6/15/202216,310,000 shares $77.15 million +1.8%25.6%17.9 $4.73 5/31/202216,030,000 shares $66.36 million +5.6%25.4%13 $4.14 5/15/202215,180,000 shares $60.57 million -2.9%24.1%11.9 $3.99 4/30/202215,640,000 shares $80.23 million -6.0%26.4%12.3 $5.13 4/15/202216,630,000 shares $89.64 million +5.3%28.1%13 $5.39 3/31/202215,800,000 shares $79.79 million +29.7%26.7%12.3 $5.05 3/15/202212,180,000 shares $73.20 million +21.7%21.0%9 $6.01 2/28/202210,010,000 shares $72.47 million +6.0%17.3%11.3 $7.24 2/15/20229,440,000 shares $64.38 million +9.6%16.4%12.4 $6.82 1/31/20228,610,000 shares $48.90 million +2.7%14.9%12.9 $5.68 1/15/20228,380,000 shares $50.62 million +10.1%14.5%14.8 $6.04 12/31/20217,610,000 shares $58.90 million +22.4%13.2%15.1 $7.74 12/15/20216,220,000 shares $55.98 million +17.4%10.8%13 $9.00 11/30/20215,300,000 shares $50.62 million +7.1%9.9%12.1 $9.55 11/15/20214,950,000 shares $54.70 million No Change9.3%10.7 $11.05 10/29/20214,950,000 shares $69.00 million +3.8%9.2%11.5 $13.94 10/15/20214,770,000 shares $63.35 million +11.7%8.9%11 $13.28 9/30/20214,270,000 shares $63.20 million +10.3%8.0%9.1 $14.80 9/15/20213,870,000 shares $51.01 million +15.2%5.2%8.2 $13.18 8/31/20213,360,000 shares $53.05 million +10.2%4.4%7.1 $15.79 8/13/20213,050,000 shares $45.17 million No Change4.0%6.7 $14.81 LYEL Short Interest - Frequently Asked Questions What is Lyell Immunopharma's current short interest? Short interest is the volume of Lyell Immunopharma shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 19,970,000 shares of LYEL short. 16.91% of Lyell Immunopharma's shares are currently sold short. Learn More on Lyell Immunopharma's current short interest. What is a good short interest ratio for Lyell Immunopharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LYEL shares currently have a short interest ratio of 22.0. Learn More on Lyell Immunopharma's short interest ratio. What is a good short interest percentage for Lyell Immunopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 16.91% of Lyell Immunopharma's floating shares are currently sold short. Is Lyell Immunopharma's short interest increasing or decreasing? Lyell Immunopharma saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 19,970,000 shares, an increase of 9.5% from the previous total of 18,230,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Lyell Immunopharma's float size? Lyell Immunopharma currently has issued a total of 254,940,000 shares. Some of Lyell Immunopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lyell Immunopharma currently has a public float of 118,130,000 shares. How does Lyell Immunopharma's short interest compare to its competitors? 16.91% of Lyell Immunopharma's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Lyell Immunopharma: Pharvaris (0.30%), AnaptysBio, Inc. (18.06%), GH Research PLC (5.05%), Mineralys Therapeutics, Inc. (4.46%), Calliditas Therapeutics AB (publ) (0.03%), Phathom Pharmaceuticals, Inc. (41.92%), ALX Oncology Holdings Inc. (11.46%), Silence Therapeutics plc (0.99%), Pharming Group (0.01%), Arbutus Biopharma Co. (3.08%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Lyell Immunopharma stock? Short selling LYEL is an investing strategy that aims to generate trading profit from Lyell Immunopharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lyell Immunopharma? A short squeeze for Lyell Immunopharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LYEL, which in turn drives the price of the stock up even further. How often is Lyell Immunopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LYEL, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: PHVS Short Squeeze ANAB Short Squeeze GHRS Short Squeeze MLYS Short Squeeze CALT Short Squeeze PHAT Short Squeeze ALXO Short Squeeze SLN Short Squeeze PHAR Short Squeeze ABUS Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LYEL) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersWARNING about the death of the U.S. dollar…Colonial MetalsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersDigitizing the $11T commodities sector with one tiny stockResource Stock DigestBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsHe Is Giving Away BitcoinCrypto Swap ProfitsElon’s New Device is About to Shock the WorldInvestorPlaceTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lyell Immunopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.